Oncology Clinical Development Market : Global Industry Analysis and Opportunity Assessment, 2036

Future Market Insights

Oncology Clinical Development Market

Key Insight

The oncology clinical development market is segmented by phase, cancer type, service, sponsor type, and region. Phase I leads with a 35.8% market share, while Breast Cancer accounts for 38.6% of the cancer type segment in 2026.

July 30, 2026

Anurag Sharma

250 Pages

Cite this Report

Oncology Clinical Development Market

https://www.futuremarketinsights.com/reports/oncology-clinical-development-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

IQVIA
Syneos Health
Parexel
ICON plc
Medpace
Fortrea
Thermo Fisher Scientific (PPD)
Precision for Medicine

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Oncology Clinical Development Market

Key Players

Similar Industry Reports